Edenred Falls 4% at Close Following Brazilian Decree Shock

Tough Trading Session for Edenred

The trading session on Wednesday, November 12, was challenging for Edenred, closing at 20.34 euros after losing 4.01% compared to the previous day (21.19 euros). The stock had opened significantly lower that morning, reflecting the immediate reaction of investors to the announcement of the Brazilian decree. Trading volumes were high with 1.86% of the capital traded, indicating a marked selling trend. Over the past week, the decline has now reached 12.85%, extending a downward trend that began several months ago. Over three months, the correction amounts to 20.55%, and over a year, Edenred has lost 32.4%. This significant erosion contrasts with the performance of the CAC 40, which has gained 10.97% over the same annual period and rose 1.04% this Wednesday, highlighting the divergence with the rest of the Paris market.

Significant Financial Impact Anticipated by Edenred

Edenred now anticipates a significant financial impact, projecting an organic EBITDA decrease for 2026 between 8% and 12%, a deviation of 10 to 16 percentage points from the previous growth forecasts of +2% to +4%. In absolute terms, Edenred expects a negative impact of 150 million to 200 million euros on EBITDA growth in 2026. Analysts from Jefferies estimate that the impact on the earnings per share for 2026 could reach 14% to 23%, while JPMorgan considers this revision more significant than expected. Kepler Cheuvreux, maintaining its buy recommendation with a target price of 40 euros, notes that these measures will compress margins through the dual effect of commission capping and reduced financial float. However, the group has maintained its outlook for 2027 and 2028 as part of its Amplify25-28 plan, with an annual organic EBITDA growth between +8% and +12% and a free-cash-flow conversion rate on EBITDA of 65% or higher.

Brazilian Decree Part of a Broader Context of Pressure

The Brazilian decree is part of a context where Edenred has been under pressure for several months. Last April, the stock had already suffered a significant correction following rumors of a possible unfavorable regulatory reform in Brazil, particularly the potential replacement of traditional cards by the Pix instant payment system. These recurring fears have weighed on the group's valuation throughout 2025. The exposure to the Brazilian market, which represents nearly 10% of the group's operational revenues as mentioned during the investor day on November 4, now constitutes a major risk factor for Edenred's financial trajectory. Edenred and Pluxee intend to take legal action against a text that would significantly penalize their profits, a strategy that could delay the application of the decree but whose outcome remains uncertain. The market's reaction this Wednesday underscores the extent of investors' concerns. The stock recorded the largest drop in the CAC 40 in the morning before slightly reducing its losses at the end of the day. Competitor Pluxee, whose activity in Brazil represents 29% of total revenue (compared to 19% for Edenred according to some estimates), was even more penalized with a decline exceeding 11% during the day. Investment bank analysts, including Barclays and UBS, quickly published their impact estimates, highlighting that the Brazilian meal voucher sector is facing a profound restructuring of its economic model. For investors, the central question now concerns Edenred's ability to offset this Brazilian profitability loss through growth in other geographies and business segments, in a context of already significantly degraded valuation over the year.